Skip to product information
1 of 1

FDA ANDA 214850, ERIBULIN MESYLATE, LONG GROVE PHARMS, 07/18/2024

FDA ANDA 214850, ERIBULIN MESYLATE, LONG GROVE PHARMS, 07/18/2024

Regular price $280.29 USD
Regular price Sale price $280.29 USD
Sale Sold out

Contents: Approval letter, executive summary, quality assessment data sheets

ANDA: 214850
Company: LONG GROVE PHARMS
Drug Name: ERIBULIN MESYLATE
Active Ingredients: ERIBULIN MESYLATE
Strength: 1MG/2ML (0.5MG/ML)
Dosage Form/Route: SOLUTION;INTRAVENOUS
Action Date: 07/18/2024
Marketing Status: Prescription
Submission Classification: ORIG-1

60 Pages

View full details
FOIA Pro

This drug has a lot more FDA history than one product page can show

FOIA Pro gives you full-text search across 70,000+ FDA FOIA records, from 2020 through today, plus a monthly monitor tracking new requests as they close.
  • Full-text search across every FDA FOIA log since 2020
  • Warning letters, approval records, and correspondence in one place
  • Monthly FDA FOIA Monitor newsletter, included
  • Cancel anytime, monthly or annual billing
Get FOIA Pro
Live search · FOIA database
Searching related FDA records…
ClosedTypeSubjectOutcome